|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
SCIDIR_ocn899211428 |
003 |
OCoLC |
005 |
20231120111934.0 |
006 |
m o d |
007 |
cr ||||||||||| |
008 |
150105t20152015enka ob 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d EBLCP
|d N$T
|d OPELS
|d OCLCF
|d YDXCP
|d DEBSZ
|d MMU
|d E7B
|d CHVBK
|d ABH
|d OCLCQ
|d U3W
|d AU@
|d OCLCO
|d MERER
|d OCLCO
|d WYU
|d OCLCO
|d OCLCA
|d OCLCQ
|d OCLCA
|d OCLCQ
|d UKMGB
|d S2H
|d OCLCO
|d VT2
|d OCLCA
|d OCLCO
|d OCL
|d OCLCQ
|
015 |
|
|
|a GBB4F3885
|2 bnb
|
016 |
7 |
|
|a 101652484
|2 DNLM
|
016 |
7 |
|
|a 016991604
|2 Uk
|
019 |
|
|
|a 900888569
|a 1066460805
|a 1235827569
|
020 |
|
|
|a 9780124166615
|q (electronic bk.)
|
020 |
|
|
|a 012416661X
|q (electronic bk.)
|
020 |
|
|
|z 9780124166035
|q (print)
|
020 |
|
|
|z 0124166032
|q (print)
|
020 |
|
|
|z 9781137502940
|q (epub)
|
035 |
|
|
|a (OCoLC)899211428
|z (OCoLC)900888569
|z (OCoLC)1066460805
|z (OCoLC)1235827569
|
050 |
|
4 |
|a RS162
|
060 |
|
4 |
|a QV 778
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
082 |
0 |
4 |
|a 615.3/6
|
245 |
0 |
0 |
|a Novel approaches and strategies for biologics, vaccines and cancer therapies /
|c edited by Manmohan Singh, Maya Salnikova.
|
264 |
|
1 |
|a London ;
|a Waltham, MA ;
|a San Diego, CA :
|b Academic Press, an imprint of Elsevier,
|c [2015]
|
264 |
|
4 |
|c �2015
|
300 |
|
|
|a 1 online resource (x, 509 pages) :
|b illustrations (chiefly color)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a Section I: Novel therapeutic approaches. Clinical considerations in the design, evaluation, and development of novel therapies -- New era in gene therapy -- Advances in nanotechnology-based drug delivery platforms and novel drug delivery systems -- Novel approaches for the delivery of biologics to the central nervous system -- Trends in nonparenteral delivery of biologics, vaccines and cancer therapies -- Section II: Novel approaches for biologics. Novel generation of antibody-based therapeutics -- Novel approaches in discovery and design of antibody-based therapeutics -- Novel therapeutic proteins and peptides -- Biobetter biologics -- Section III: Novel approaches for vaccines. Vaccines against non-infectious, non-cancer novel targets -- Winning a race against evolving pathogens with novel platforms and universal vaccines -- Prime-boost vaccination: impact on the HIV-1 vaccine field -- Section IV: Novel approaches for cancer therapies. Personalized therapies for cancer treatment -- Hunting molecular targets for anticancer reagents by chemical proteomics -- Cancer vaccines -- T-cell immunotherapy for cancer -- Immunostimulators and immunomodulators in cancer treatment -- Long-circulating therapies for cancer treatment -- Recent advances and trends in the brain delivery of small molecule based cancer therapies.
|
520 |
|
|
|a Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies takes a look at the current strategies, successes and challenges involved with the development of novel formulations of biologics, vaccines and cancer therapy. This thorough reference on the latest trends in the development of diverse modalities will appeal to a broad community of scientists, students and clinicians. Written by leading authors across academia and industry, this book covers important topics such as unique drug delivery devices, non-parenteral delivery trends, novel approaches to the treatment of cancer, immunotherapy and more. It includes real-world cases and examples which highlight formulations with therapeutic proteins, monoclonal antibodies, peptides and biobetters, as well as cases on novel vaccines formulations including evolving pathogens, novel modalities of vaccines, universal vaccines. This book is a thorough and useful resource on the development of novel biologics, vaccines and cancer therapies.
|
588 |
0 |
|
|a Online resource; title from electronic title page (ebrary, viewed on June 18, 2015).
|
650 |
|
0 |
|a Biologicals.
|
650 |
|
0 |
|a Vaccines.
|
650 |
|
0 |
|a Cancer
|x Treatment.
|
650 |
|
0 |
|a Pharmaceutical technology.
|
650 |
1 |
2 |
|a Technology, Pharmaceutical
|0 (DNLM)D013678
|
650 |
2 |
2 |
|a Biological Factors
|0 (DNLM)D001685
|
650 |
2 |
2 |
|a Neoplasms
|x therapy
|0 (DNLM)D009369Q000628
|
650 |
2 |
2 |
|a Vaccines
|0 (DNLM)D014612
|
650 |
|
6 |
|a Produits biologiques.
|0 (CaQQLa)201-0003884
|
650 |
|
6 |
|a Vaccins.
|0 (CaQQLa)201-0018490
|
650 |
|
6 |
|a Cancer
|x Traitement.
|0 (CaQQLa)201-0004693
|
650 |
|
6 |
|a Techniques pharmaceutiques.
|0 (CaQQLa)201-0138380
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a Pharmaceutical technology.
|2 fast
|0 (OCoLC)fst01060211
|
650 |
|
7 |
|a Biologicals.
|2 fast
|0 (OCoLC)fst00832374
|
650 |
|
7 |
|a Cancer
|x Treatment.
|2 fast
|0 (OCoLC)fst00845538
|
650 |
|
7 |
|a Vaccines.
|2 fast
|0 (OCoLC)fst01163573
|
700 |
0 |
|
|a Manmohan Singh,
|d 1964 November 8-
|e editor.
|
700 |
1 |
|
|a Salnikova, Maya,
|e editor.
|
776 |
0 |
8 |
|i Print version:
|t Novel approaches and strategies for biologics, vaccines, and cancer therapies.
|d Amsterdam : Elsevier/AP, [2015]
|z 9780124166035
|w (OCoLC)907021491
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780124166035
|z Texto completo
|